Abstract:Introduction: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US, and more than 1.2 million patients are diagnosed with CRC worldwide annually, with 5 year survival rates of ~64%.Accumulating evidence indicates that epigenetic modifications play a critical role in progression of CRC.In particular, over the last decade, dysregulated expression of microRNAs (miRNAs) has been established as a hallmark of cancer.Exportin-5 (XPO5), a member of the karyopherin family, is a key protein responsible for the transportation of precursor miRNAs from the nucleus to the cytoplasm.While XPO5 is perhaps the most critical regulator during miRNA biogenesis, the clinical usefulness of XPO5 expression alteration as a potential biomarker in CRC remains unexplored.Aims: We aimed to investigate the clinical significance of XPO5 expression in CRC, and determine its functional role in CRC.Materials and Methods: The expression level of XPO5 was systematically assessed in three independent microarray-based datasets.The relationship between XPO5 expression and clinicopathological features was subsequently validated in two independent CRC patient cohorts.A functional characterization of the role of XPO5 in CRC was examined by targeted gene silencing in a panel of cell lines and xenograft animal models.Finally, we correlated XPO5 expression and alterations in miRNA signatures in CRC.Results: Three independent microarray dataset analyses in the discovery step revealed that XPO5 was consistently among the top 1% overexpressed genes in CRCs compared with normal tissues.High-XPO5 expression associated with worse clinicopathological features including depth of invasion and distant metastasis in two independent patient cohorts.Moreover, CRC patients with high-XPO5 expression demonstrated significantly worse overall survival.SiRNA knockdown of XPO5 in CRC cell lines resulted in reduced cellular proliferation and invasion, and the induction of G1/S cell cycle arrest.Expression levels of key oncogenic miRNAs were downregulated following inhibition of XPO5 in CRC cells, which was consistent with our observation that the expression of oncogenic miRNA clusters correlates positively with XPO5 expression in CRC tissues.Finally, we validated our in-vitro results by demonstrating that silencing of XPO5 resulted in the attenuation of tumor growth in a xenograft animal model. Conclusion:Our results demonstrate that XPO5 acts as an oncogene in CRC through regulation of specific miRNA clusters.The association between high-XPO5 expression and poor survival in CRC patients highlights its significance as a potential prognostic marker and a therapeutic target in CRC.

Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer

Integrated Bioinformatics Analysis and Clinical Validation Reveals That High Expression of Mucin 1 in Intrahepatic Cholangiocarcinoma Predicts Recurrence after Curative Resection.

USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance

The Expression and Prognostic Significance of Mucin 13 and Mucin 20 in Esophageal Squamous Cell Carcinoma

Up-regulation of microRNA-19b is associated with metastasis and predicts poor prognosis in patients with colorectal cancer

Neuromedin U Receptor 1 Deletion Leads to Impaired Immunotherapy Response and High Malignancy in Colorectal Cancer

[Expression and clinical significance of Mucin and E-cadherin in colorectal tumors]

Application of RNA Processing Factors for Predicting Clinical Outcomes in Colon Cancer.

MUC1 Overexpression Predicts Worse Survival in Patients with Non-Small Cell Lung Cancer: Evidence from an Updated Meta-Analysis.

High Expression Of Mucin13 Associates With Grimmer Postoperative Prognosis Of Patients With Non-Metastatic Clear-Cell Renal Cell Carcinoma

Tu2063 Germline Mutations in Two Hereditary Early On-Set Gastric Cancer Families

The relationship between miR-219-5p Gene Polymorphisms and the prognosis of colorectal cancer

Decreased Expression of Mucin 18 is Associated with Unfavorable Postoperative Prognosis in Patients with Clear Cell Renal Cell Carcinoma.

Prognostic value and potential regulatory relationship of miR‐200c‐5p in colorectal cancer

Exploring the Expression and the Prognosis of Mismatch Repair Protein and PD-L1 in Colorectal Cancer

Membrane Trafficking-Related Genes Predict Tumor Immune Microenvironment and Prognosis in Colorectal Cancer.

C-Myb and Its Effector COX-2 As an Indicator Associated with Prognosis and Therapeutic Outcome in Colorectal Cancer

Mucin 1 promotes tumor progression through activating WNT/β-catenin signaling pathway in intrahepatic cholangiocarcinoma

Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer

Increased Long Noncoding RNA SNHG20 Predicts Poor Prognosis in Colorectal Cancer.

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.